Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,908 | 134 | 99.5% |
| Education | $15.27 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,222 | 54 | $0 (2024) |
| Lilly USA, LLC | $416.73 | 16 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $185.79 | 9 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $141.48 | 6 | $0 (2024) |
| Amgen Inc. | $80.60 | 2 | $0 (2020) |
| Sun Pharmaceutical Industries Inc. | $77.09 | 4 | $0 (2023) |
| Janssen Biotech, Inc. | $67.09 | 2 | $0 (2024) |
| PFIZER INC. | $64.91 | 4 | $0 (2024) |
| REVANCE THERAPEUTICS, INC. | $49.90 | 1 | $0 (2024) |
| DERMIRA, INC. | $48.30 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $481.01 | 23 | Lilly USA, LLC ($105.83) |
| 2023 | $457.46 | 26 | AbbVie Inc. ($195.71) |
| 2022 | $352.52 | 21 | ABBVIE INC. ($185.28) |
| 2021 | $502.55 | 26 | AbbVie Inc. ($312.33) |
| 2020 | $422.19 | 16 | AbbVie Inc. ($262.07) |
| 2019 | $116.83 | 7 | Almirall LLC ($20.67) |
| 2018 | $89.35 | 6 | Promius Pharma LLC ($31.27) |
| 2017 | $501.08 | 10 | AbbVie, Inc. ($243.82) |
All Payment Transactions
135 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $7.72 | General |
| Category: DERMATOLOGY | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Dermatology | ||||||
| 10/28/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Immunology | ||||||
| 10/15/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: DERMATOLOGY | ||||||
| 10/01/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $29.80 | General |
| 08/29/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $13.98 | General |
| 08/20/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: DERMATOLOGY | ||||||
| 07/09/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $49.90 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 06/27/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Immunology | ||||||
| 06/24/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $27.81 | General |
| Category: Immunology | ||||||
| 05/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/14/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: DERMATOLOGY | ||||||
| 05/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: IMMUNOLOGY | ||||||
| 05/09/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Immunology | ||||||
| 04/11/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: DERMATOLOGY | ||||||
| 04/01/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Immunology | ||||||
| 03/12/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: DERMATOLOGY | ||||||
| 03/12/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: DERMATOLOGY | ||||||
| 03/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Dermatology | ||||||
| 01/29/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Immunology | ||||||
| 01/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: Immunology | ||||||
| 01/18/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: DERMATOLOGY | ||||||
| 01/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.69 | General |
| Category: Immunology | ||||||
| 12/19/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.77 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2023 | Arcutis Biotherapeutics, Inc. | — | Food and Beverage | In-kind items and services | $17.06 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 2,159 | 7,821 | $643,925 | $206,167 |
| 2022 | 21 | 1,791 | 5,395 | $506,283 | $167,622 |
| 2021 | 13 | 1,109 | 1,679 | $210,152 | $82,316 |
| 2020 | 16 | 1,811 | 2,726 | $333,314 | $125,089 |
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 217 | 341 | $88,923 | $30,405 | 34.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 323 | 458 | $84,686 | $28,429 | 33.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 203 | 252 | $60,077 | $20,638 | 34.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 239 | 299 | $63,941 | $19,594 | 30.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 314 | 428 | $59,806 | $15,020 | 25.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 113 | 113 | $38,225 | $12,608 | 33.0% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 27 | 32 | $28,458 | $9,521 | 33.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 148 | 148 | $33,882 | $9,303 | 27.5% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 22 | 22 | $31,152 | $9,116 | 29.3% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 26 | 27 | $26,568 | $7,960 | 30.0% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 21 | 23 | $19,159 | $6,872 | 35.9% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 18 | 19 | $16,378 | $6,192 | 37.8% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 27 | 31 | $18,462 | $5,978 | 32.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 237 | 1,115 | $15,680 | $5,727 | 36.5% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2023 | 20 | 4,200 | $13,901 | $5,448 | 39.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 74 | 115 | $12,166 | $4,532 | 37.2% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 23 | 23 | $13,349 | $2,564 | 19.2% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 12 | 13 | $5,577 | $2,075 | 37.2% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 24 | 35 | $4,162 | $1,330 | 32.0% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 12 | 13 | $3,445 | $1,326 | 38.5% |
| 69100 | Biopsy of ear | Office | 2023 | 22 | 23 | $4,641 | $1,026 | 22.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 41 | $1,189 | $461.38 | 38.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 24 | 50 | $98.00 | $41.56 | 42.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 155 | 257 | $67,591 | $25,184 | 37.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 228 | 289 | $62,883 | $20,025 | 31.8% |
About Dr. Samuel Ecker, D.O
Dr. Samuel Ecker, D.O is a Dermatology healthcare provider based in Laramie, Wyoming. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/14/2013. The National Provider Identifier (NPI) number assigned to this provider is 1033555230.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Ecker, D.O has received a total of $2,923 in payments from pharmaceutical and medical device companies, with $481.01 received in 2024. These payments were reported across 135 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($2,908).
As a Medicare-enrolled provider, Ecker has provided services to 6,870 Medicare beneficiaries, totaling 17,621 services with total Medicare billing of $581,194. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Laramie, WY
- Active Since 05/14/2013
- Last Updated 09/27/2021
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1033555230
Products in Payments
- SKYRIZI (Biological) $703.35
- TALTZ (Drug) $416.73
- Humira (Biological) $243.82
- HUMIRA (Biological) $178.48
- DUPIXENT (Biological) $128.27
- Enbrel (Biological) $80.60
- COSENTYX (Biological) $68.22
- RINVOQ (Biological) $65.89
- QBREXZA (Drug) $64.99
- DAXXIFY (Drug) $49.90
- EUCRISA (Drug) $49.64
- TREMFYA (Drug) $40.00
- COSENTYX (Drug) $38.33
- LIBTAYO (Biological) $36.15
- VTAMA (Drug) $35.87
- YCANTH (Drug) $33.95
- AMELUZ (Drug) $33.87
- Puraply (Medical Supply) $32.56
- Winlevi (Drug) $32.41
- RHOFADE (Drug) $28.36
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.